Enteric fever, primarily caused by Salmonella Typhi and Paratyphi, remains a significant global health concern, particularly in low-resource settings. This article presents an updated approach to the diagnosis and management of enteric fever, incorporating recent advancements in clinical practices and diagnostic methods.
Traditional diagnostic methods, such as blood culture, have been the gold standard for enteric fever diagnosis. However, their sensitivity varies and they require a significant amount of time to yield results. Recent advancements include nucleic acid amplification tests (NAATs) and serological tests like Typhidot and Tubex-TF. NAATs offer high sensitivity and specificity, while serological tests provide rapid results, aiding in early diagnosis. However, the lack of standardization and variable performance of these tests necessitates further research and validation.
Antibiotic therapy remains the mainstay of enteric fever management. The choice of antibiotics should be guided by local antimicrobial resistance patterns. Fluoroquinolones, third-generation cephalosporins, and azithromycin are commonly used. However, the emergence of extensively drug-resistant (XDR) strains poses a significant challenge, warranting a judicious use of antibiotics. Supportive care, including hydration and fever management, is also crucial.
Prevention strategies encompass vaccination, safe food and water practices, and improved sanitation. The World Health Organization recommends the use of Typhoid Conjugate Vaccines (TCVs) in endemic areas. However, vaccination should not replace the need for improved water, sanitation, and hygiene practices. Antimicrobial stewardship programs also play a vital role in preventing the emergence and spread of resistant strains.
In conclusion, the diagnosis and management of enteric fever require a multifaceted approach, incorporating advanced diagnostic methods, effective treatment strategies, and robust prevention measures. As the landscape of enteric fever continues to evolve, healthcare professionals must stay updated with the latest practices to ensure optimal patient care and management.
1.
Toward rapid and comprehensive genetic diagnosis of pediatric cancer through adaptive sequencing
2.
Q&A: Why adolescents and young adults with cancer are falling behind
3.
Fixed-Duration Combo Shows Promise for Relapsed MCL
4.
Hospital receives 300 backpacks designed to help kids get leukemia treatment on the go
5.
A study has developed molecular markers that predict meningioma recurrence.
1.
Ultimate Guide to Oncology Services in the USA
2.
Exploring the Benefits of Teclistamab for Treating Advanced Cancer
3.
Glofitamab: A Breakthrough Therapy for Relapsed/Refractory Mantle Cell Lymphoma
4.
The Importance of Iron Rich Foods in Preventing and Treating Anemia
5.
Unexplained Weight Loss: Revealing Occult Cancers and Paraneoplastic Syndromes
1.
International Cancer Conference
2.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
3.
International Cancer Conference
4.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Updates on the First Line Management of ALK+ NSCLC
2.
Dacomitinib Case Presentation: Baseline Treatment and Current Status
3.
Recent Data Analysis for First-Line Treatment of ALK+ NSCLC: A Continuation
4.
Optimizing Treatment Options in Advanced Urothelial Carcinoma
5.
A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part II
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation